Ultrasonographic predictors of thyroid cancer in Bethesda III and IV thyroid nodules

BackgroundBethesda III and IV thyroid nodules continue to be difficult to manage. Although molecular testing may assist in decision-making, it is expensive, not widely available, and not without pitfalls. The objective of this study is to assess whether certain thyroid ultrasonographic features may...

Full description

Bibliographic Details
Published in:	Frontiers in Endocrinology
Main Authors:	Ebtihal Y. Alyusuf, Lama Alhmayin, Eman Albasri, Jawaher Enani, Hessa Altuwaijri, Nora Alsomali, Maria A. Arafah, Zahra Alyusuf, Anwar A. Jammah, Aishah A. Ekhzaimy, Ali S. Alzahrani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Subjects:	Bethesda III Bethesda IV predictors thyroid cancer ultrasonography
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1326134/full

Similar Items

The 2023 Bethesda System for Reporting Thyroid Cytopathology: A review update
by: A. Parmar Riddhi, et al.
Published: (2024-10-01)

Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management
by: Wen-Hui Chan, et al.
Published: (2024-11-01)

Does the Bethesda category predict aggressive features in differentiated thyroid cancer?
by: Ana Rafaela Lopes Reis Lima, et al.

Cancer rate of Bethesda category II thyroid nodules
by: Francesk Mulita, et al.
Published: (2022-02-01)

Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy
by: Jennifer Lourdes Ng, et al.
Published: (2023-08-01)

The Importance of Using ACR-TIRADS Scoring System and Bethesda Classification System Together in the Diagnosis of Thyroid Cancer
by: Serhan Yılmaz, et al.
Published: (2021-04-01)

Clinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study
by: Adeel Ahmad Khan, et al.
Published: (2025-09-01)

The Role of “Critical” Ultrasound Reassessment in the Decision-Making of Bethesda III Thyroid Nodules
by: Giuseppina Orlando, et al.
Published: (2023-08-01)

Use of the Bethesda system for the cytologic diagnosis of thyroid nodules
by: Rafael Escalona Veloz
Published: (2023-01-01)

Reproducibility of ‘The Bethesda System for reporting Thyroid Cytopathology’: A MultiCenter Study with Review of the Literature
by: Tejinder Singh Bhasin, et al.
Published: (2013-06-01)

Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS)
by: Francesk Mulita, et al.
Published: (2021-04-01)

EFFECT OF ANATOMO-TOPOGRAPHIC AND SONOGRAPHIC POLARITY OF THE THYROID NODULES ON THE THYROID MALIGNANCY BY EVALUATING ITS IMPRESSION ON THE RELATIONSHIP BETWEEN THE BETHESDA SYSTEM, TBSRTC, STRAIN ELASTOGRAPHY SCORE AND THE THYROID HISTOPATHOLOGY
by: Sengul Demet, et al.
Published: (2019-05-01)

An Analysis of Thyroid Fine Needle Aspiration Biopsy Results According to the Bethesda System for Reporting Thyroid Cytopathology: A Cross-Sectional Retrospective Study
by: Bilal Sızer, et al.
Published: (2023-03-01)

Malignancy rates for Bethesda III subcategories in thyroid fine needle aspiration biopsy (FNAB)
by: Leticia Mosca, et al.
Published: (2018-05-01)

The sensitivity and specificity of fine needle aspiration cytology in detecting thyroid malignancy according to Bethesda system at a teaching hospital in Saudi Arabia
by: Fahd A. Refai, et al.
Published: (2024-10-01)

Is Evaluation of Serum Calcitonin Levels Significant for Patients with Thyroid Nodules?
by: Cevdet Aydın, et al.
Published: (2020-09-01)

The Role of Ultrasound as a Predictor of Malignancy in Indeterminate Thyroid Nodules—A Multicenter Study
by: Reem J. Al Argan, et al.
Published: (2025-06-01)

Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing
by: Maria Mavromati, et al.
Published: (2023-10-01)

Diagnostic accuracy and utility of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), 2017 in an Indian Scenario: A tertiary care appraisal
by: Sujata Raychaudhuri, et al.
Published: (2024-01-01)

Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results
by: Pi-Ling Chiang, et al.
Published: (2023-10-01)

The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up
by: Santosh Kumar Mondal, et al.
Published: (2013-01-01)

Prognostic significance of the Bethesda cytological classification in recurrent thyroid carcinoma
by: I. M. Zakharova, et al.
Published: (2025-07-01)

Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations
by: Laura Fugazzola, et al.
Published: (2024-05-01)

Reproducibility of “The bethesda system for reporting thyroid cytopathology:” A retrospective analysis of 107 patients
by: Pragati Awasthi, et al.
Published: (2018-01-01)

Assessment of thyroid lesions using fine-needle aspiration cytology in accordance with The Bethesda System and its histopathological correlation
by: Himachal Mishra, et al.
Published: (2023-07-01)

Evaluation of thyroid lesions by the bethesda system for reporting thyroid cytopathology
by: Syed Asif Hashmi, et al.
Published: (2023-01-01)

What Should Be Considered in Bethesda III Thyroid Nodules When Prefering Hemitioidectomy or Total Thyroidectomy
by: Fazilet Altın, et al.
Published: (2020-06-01)

applications of the bethesda system for cervical cytological reporting
by: nada S. AL-Rubai'ee, et al.
Published: (2006-04-01)

Sadzawka Bethesda (J 5, 2) w patrystycznej i współczesnej egzegezie
by: Bogusław Górka
Published: (1999-12-01)

Diagnostic efficacy of brafv600e immunocytochemistry in thyroid aspirates in bethesda category iv and papillary thyroid carcinoma
by: Nidhi Anand, et al.
Published: (2021-01-01)

Efficacy and safety of thermal ablation for Bethesda III/IV thyroid nodules: a retrospective study
by: Song Li, et al.
Published: (2025-05-01)

Inter-Reader Agreement of ATA Sonographic Risk in Thyroid Nodules with Bethesda Category III Indeterminate Cytology
by: Maria I. Linares Valderrama, et al.
Published: (2021-04-01)

The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists
by: Mimi Kim, et al.
Published: (2017-07-01)

FINE NEEDLE ASPIRATION CYTOLOGY AS A FIRST LINE INVESTIGATION IN THYROID LESIONS
by: Mandakini M Patel, et al.
Published: (2013-03-01)

Evaluation of Sonographic Features with TIRADS of Malignant Cytology, Suspicious for Malignancy, and Follicular Neoplasm Thyroid Nodules According to the Bethesda Reporting System
by: Hülya ÇETİN TUNÇEZ, et al.
Published: (2024-04-01)

Correlation between Ultrasound TI-RADS and Bethesda FNAC Scoring in Thyroid Lesions: A Retrospective Analysis
by: Smriti Mathur, et al.
Published: (2023-06-01)

Cytomorphological Spectrum of Thyroid Lesions Based on Bethesda Reporting System: Diagnostic Utility and Pitfalls
by: Naval Kishore Bajaj, et al.
Published: (2023-04-01)

A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin
by: Aishah A. Ekhzaimy, et al.
Published: (2022-01-01)

A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience
by: P. Arul, et al.
Published: (2015-12-01)

Real-world EUROCRINE® registry data challenge the reliability of Bethesda cytopathology for thyroid surgery indication
by: Staubitz Julia I., et al.
Published: (2021-08-01)